Form 13-F position report

* DOLBY LABORATORIES INC

Reported by Pacer Advisors Inc

DLB CUSIP 25659T107 Manager CIK 0001616667

First reported at 1,403 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q1 2023
Shares 1,403 Quarter-end amount reported
Reported value $119,844 Fair value at quarter end
Consecutive quarters held 1 Through Q1 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 119844
2023-06-30 338653
2023-09-30 603961
2023-12-31 1414903
2024-03-31 1324487
2024-06-30 1847644
2024-09-30 1011880
2024-12-31 3219516
2025-03-31 13073424
2025-06-30 16633943
2025-09-30 32124826
2025-12-31 30690931
2026-03-31 31008000
2026-06-30 378000

Quarterly position history

How this manager's reported quarter-end position changed over time.

14 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by Pacer Advisors Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 7,194 -509,098 (-98.6%) < 0.01% $378,000 2026-08-13
Q1 2026 Added 516,292 +38,389 (8.0%) 0.09% $31,008,000 2026-05-06
Q4 2025 Added 477,903 +34,006 (7.7%) 0.08% $30,690,931 2026-02-04
Q3 2025 Added 443,897 +219,901 (98.2%) 0.08% $32,124,826 2025-10-15
Q2 2025 Added 223,996 +61,209 (37.6%) 0.04% $16,633,943 2025-08-12
Q1 2025 Added 162,787 +121,564 (294.9%) 0.03% $13,073,424 2025-05-06
Q4 2024 Added 41,223 +28,001 (211.8%) < 0.01% $3,219,516 2025-01-22
Q3 2024 Reduced 13,222 -10,098 (-43.3%) < 0.01% $1,011,880 2024-11-12
Q2 2024 Added 23,320 +7,509 (47.5%) < 0.01% $1,847,644 2024-08-13
Q1 2024 Reduced 15,811 -607 (-3.7%) < 0.01% $1,324,487 2024-05-10
Q4 2023 Added 16,418 +8,798 (115.5%) < 0.01% $1,414,903 2024-01-16
Q3 2023 Added 7,620 +3,573 (88.3%) < 0.01% $603,961 2023-11-13
Q2 2023 Added 4,047 +2,644 (188.5%) < 0.01% $338,653 2023-07-12
Q1 2023 New 1,403 +1,403 (0.0%) < 0.01% $119,844 2023-05-02
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

449 managers reported * DOLBY LABORATORIES INC for Q1 2023.

Managers reporting * DOLBY LABORATORIES INC in Q1 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 6,046,476 +82,804 0.01% $516,489,980 40 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Added 5,265,758 +154,954 1.32% $449,801,096 12 qtrs
MORGAN STANLEY Reduced 4,324,588 -41,244 0.04% $369,406,440 40 qtrs
BlackRock Inc Added 3,118,854 +1,069 < 0.01% $266,412,512 40 qtrs
Clearbridge Investments LLC Reduced 2,818,043 -85,350 0.23% $240,717,240 40 qtrs
Ninety One UK Ltd Reduced 2,252,508 -74,266 0.6% $192,409,234 7 qtrs
MACKENZIE FINANCIAL CORP Added 1,497,869 +7,286 0.2% $127,947,970 21 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 1,465,511 +63,225 0.03% $125,183,915 40 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Reduced 1,457,873 -154,735 3.2% $124,531,512 40 qtrs
WELLS FARGO & COMPANY MN Added 1,187,114 +10,111 0.03% $101,403,437 40 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2023
Filed
May 02, 2023
Filing type
13F-HR
Position type
Common Stock - Domestic

Voting authority reported

Sole
119,844
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.